Xinxiang first people's hospital
Welcome,         Profile    Billing    Logout  
 3 Trials 
5 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Guo, Zhiyong
NCT02946528: Urgent-start Peritoneal Dialysis in ESRD Patients:A Multi-center Study

Completed
N/A
116
RoW
urgent-start peritoneal dialysis catheter, central venous catheter
RenJi Hospital, Ruijin Hospital, Xin Hua Hospital, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Changhai Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai Tong Ren Hospital, Shanghai Jiading District Central Hospital, Shanghai Songjiang District Central Hospital, The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Shanghai Punan Hospital
End-Stage Renal Disease
11/21
11/21
NCT05639010: Benefits of Hemodialysis Plus Hemoperfusion: A Clinical Study

Recruiting
N/A
410
RoW
regular hemodialysis, hemoperfusion combined with hemodialysis
Changhai Hospital
End Stage Renal Disease
12/25
12/25
NCT05761938: A Study of Rituximab in Frontline Therapy for Glomerulonephritis

Recruiting
N/A
100
RoW
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Glomerulonephritis
12/24
12/25
NCT05289609: Developing Prediction Models for Allograft Failure After Liver Transplantation

Not yet recruiting
N/A
5000
Europe, Canada, Japan, US, RoW
Liver Transplantation
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, University of California, Los Angeles, University Hospital Padova, Mayo Clinic, Hospital Italiano de Buenos Aires, Tokyo Women's Medical University, Hospital Universitario La Paz, First Affiliated Hospital, Sun Yat-Sen University, University of Roma La Sapienza, University of Massachusetts, Worcester, The Cleveland Clinic, Dr. Rela Institute & Medical Centre, University of Toronto, Universidade Federal do Paraná, Royal Infirmary of Edinburgh, Erasmus Medical Center
Liver Transplant Disorder
12/23
04/24
Zhang, Chunhui
NCT06083623: A Trial to Evaluate the Efficacy and Safety of TNM001 for the Prevention of Lower Respiratory Tract Infection Caused by Respiratory Syncytial Virus in Infants

Not yet recruiting
2b
2250
RoW
TNM001, placebo
Zhuhai Trinomab Pharmaceutical Co., Ltd.
Respiratory Syncytial Virus Infections
05/26
08/26

Download Options